Recent clinical trials have challenged the standard practice of using a restrictive Red Blood Cell (RBC) transfusion strategy for critically ill brain-injured patients (ABI).

Restrictive Approach is Questioned: The prevailing idea that a restrictive strategy is safe for ABI patients is now being disputed by new evidence.

Liberal Strategy for Neuroprotection: Maintaining hemoglobin (Hb) levels over 9 or 10 g/dL is now suggested, as it may offer neuroprotective benefits, especially in the vulnerable early phase following injury, by preventing anemia-induced hypoxia.

Physiological Alignment: This more liberal approach aligns better with the high metabolic demands of the injured brain and is supported by the improved safety profile of modern blood products.

Guidelines Gap: Current international guidelines recommend a restrictive strategy for the general ICU population, but the trials supporting this often excluded or underrepresented ABI patients. Furthermore, those trials focused on short-term mortality, whereas the key outcome for ABI patients is long-term neurologic function.

Future Directions: While a more liberal approach is supported, the text also suggests incorporating blood-conservation strategies (like minimizing blood draws) and notes the potential for individualized transfusion strategies using advanced cerebral oxygenation monitoring, though this needs further study.

Read More